(Q46495720)

22 December 2017

title

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone (English)

1 reference

22 December 2017

author

Eduard Vieta

1

1 reference

22 December 2017

Adriane R Rosa

object named as

Adriane R Rosa

4

0 references

author name string

Evaristo Nieto

2

1 reference

22 December 2017

Aurea Autet

3

1 reference

22 December 2017

José M Goikolea

5

1 reference

22 December 2017

Nuria Cruz

6

1 reference

22 December 2017

Pere Bonet

7

1 reference

22 December 2017

language of work or name

1 reference

1 January 2008

1 reference

22 December 2017

World Journal of Biological Psychiatry

published in

1 reference

22 December 2017

volume

9

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

219-224

1 reference

22 December 2017

Long-term depot antipsychotics. A risk-benefit assessment

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Long-term observational comparison of risperidone and olanzapine in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Using drug claims data to assess the relationship of medication adherence with hospitalization and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Evolving trends in the long-term treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Acute and continuation risperidone monotherapy in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

Cost of relapse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701530917

10.1080/15622970701530917

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017